METHODS
Family physicians working in primary health care services were visited face-to-face at their places of work. Of 93 family physicians in the province of Düzce, 50 (53.76%) physicians who were available at their facilities on the day of visit and who accepted to participate in the study were included in the study. For each family physician, a questionnaire form was completed at the beginning. The questionnaire consisted of questions related to age, gender, and the duration of working as a family physician. Moreover, they were asked about the names of inhaler devices that they knew and whether they prescribed inhaler devices to their patients; if the answer was a yes, then they were further questioned as which methods they used,and if the answer was a no, then they were asked as why they did not prescribe the inhaler device. Then, the usage techniques of seven different inhalation devices were evaluated in 10 steps over 10 points. The inhaler devices, the uses of which were evaluated, were MDI (GlaxoSmithKline, Brendford, England), discus (GlaxoSmithKline, Brendford, England), turbuhaler (Astrazenaca, London, England), aerolizer (Novartis, Basel, Switzerland), easyhaler (Abdi İbrahim, İstanbul, Turkey), handihaler (Pfizer, New York, USA), sanohaler (Sanovel, İstanbul, Turkey). The steps used for each inhalation are presented in Table 1 . Each correct step was scored as one point and each incorrect or non-applied step was scored as zero. Total scores were accepted as the skill score. Written informed consent was obtained from all participants. The approval for the study was obtained from the Ethics Committee of the Düzce University Faculty of Medicine (Decision No: 2013/365).
Statistical Analysis
The skill scores of the family physicians were calculated as mean value ± standard deviation for each device. For statistical analyses, the 
RESULTS
Of the family physicians who participated in the study, 28 (56%) were females and 22 (44%) were males. The mean age was 36.3±6.7 years, and the mean working time as a family physician was 5.12±2.8 years. Nineteen (38%) family physicians had participated in an education program on the usage of inhaler device. Of the family physicians, 22 (44%) stated that they knew how to use inhaler devices, 25 (50%) had some knowledge regarding their use, and 3 (6%) had no knowledge. The distribution of the names of inhaler devices that they knew is presented in Figure  1 . The most commonly known inhaler device by family physicians (43 physicians) was MDI followed by discus, handihaler, turbuhaler, aerolizer, and easyhaler. Sanohaler was not known by family physicians. Table 2 shows how 47 physicians learned to use the devices.
Twenty-nine of the physicians stated that they provided education on the usage of inhaler devices to their patients, but 21 physicians did not. One physician told that he only prescribed MDI to patients, thereby providing education on the use of MDI. The reasons for not providing education are summarized in Table 3 . Most of the physicians stated that they did not provide education because they thought that it must have been provided by the physician who had prescribed the device for the first time. Moreover, specialists in chest diseases, family physicians, pharmacists, pharmacy technicians, and educated nurses were specified as the health staff who could provide education (Table 4 ).
It was revealed that the family physicians who provided education to their patients frequently asked them to use the inhaler devices that they carried with them and checked whether they used it correctly. When the patients used it incorrectly, physicians warned and corrected them. Only one physician stated that he had an MDI device for demonstration purposes and showed its usage to patients for whom he had prescribed that device. There was no other physician who had a brochure regarding inhaler devices or a demonstration device at the work place.
Six of the family physicians told that they knew all the steps in the use of seven different inhaler devices, but two did not know anything regard- During the education in the faculty of medicine 5 10 With the visits of medical representatives 4 8
By examining drug brochures 4 8
Because of using the device for their own disease 1 2 *Participants stated more than one way of learning The physician who first prescribed the device 17
Pharmacist and pharmacy technician 6
Nurse 6
Everybody who knows the devices (another patient, patient's relative, etc.) 5 *Some physicians gave more than one answer Table 4 . The suggestions of family physicians about the person who must provide education on inhaler device to patients Figure 1 . The distributions of the types of inhaler devices that were specified to be known by family physicians *Participants told one or more device names MDI: Metered-dose inhaler Table 5 .
DISCUSSION
On evaluating the approach of primary care physicians to the education on inhaler devices in our study, it was found that several physicians (42%) did not provide education on the usage of these devices to their patients. Most did not feel the need to provide education because they thought that "the physician who had firstly prescribed the device or a pharmacist or pharmacy technician must have explained its usage. " However, in our study, the scores for the usage of inhaler device were significantly lower in physicians who did not provide education on inhaler devices to their patients than in physicians who provided education. It was observed that the family physicians with the highest skill scores for the devices, except MDI, the oldest and the most conventional inhaler device, and sanohaler, the last inhaler to be introduced in the market, explained their usage to their patients. This result can indicate that there is no problem regarding the knowledge and explanation of MDI, but there is not yet enough knowledge on sanohaler device. For obtaining efficiency similar to that associated with systemic treatment, fewer medications are used in inhalation treatment than those used in systemic treatment. This also decreases systemic side-effects. However, patient compliance and the correct use of inhalation devices are important for this treatment method to be effective. Considering the facts that only 15%-20% of the inhaler aerosol particles reach the lungs even under the best conditions and the amount of drug stored in the lungs can increase from 7.2% to 22.8% if appropriate techniques are used, it is clear that accurate usage of inhaler devices is very important (9) . According to the studies conducted previously, few differences are seen among different inhaler devices with regard to efficiency if they are accurately used. However, many patients do not use inhaler devices correctly (10, 11) . In the studies conducted in Turkey, the rate of correct usage of inhaler devices by patients was found to be quite low (5, 12) . For preventing the errors made in the usage of all inhalation devices, all health staff should pay attention to the education on inhaler use as a part of treatment (13).
The results of the study also suggested that the family physicians who did not provide education avoided doing so because they did not have the knowledge regarding the usage of the inhaler devices. It is surely beyond doubt that the prescribing physician has the primary responsibility. However, other health workers also have a role in the evaluation of the correct usage of the inhaler device and in patient education (14) . It is proved that education is not always given by an appropriate person. Device education involves a vast majority of health staff, including physicians, nurses, and pharmacists. Health workers should not oversimplify education thinking that the education must have already been given, and they should have adequate knowledge on inhaler techniques (15) . The physicians participating in our study agreed that device techniques should be explained to patients by a specialist in chest diseases, family physician, pharmacist, pharmacy technician, nurse, and anyone who has (11) . One physician assumed that the patient had learned how to use the device from its brochure. Lenney et al. (16) compared patients learning the usage of MDI from the brochure and from a physician, and they found that the rates of correct usage were 21% in patients who learned from the brochure and 52% in patients who were educated by a physician. The family physicians providing education regarding the usage of inhaler devices stated that they mostly did this to check whether the patients with devices used them correctly. Except one physician, there was no family physician having a demonstration device and brochure at their work places. Only 19 physicians (38%) told that they had attended a meeting in which education had been provided on inhaler devices, and that they had been educated via a slide show and by using demonstration devices in groups. Other physicians learned the usage of the devices by trying it with their patients or with a family member who used the device or by using it for treating their own diseases. The skill scores of physicians who received the education were significantly higher than physicians who did not. These results show the importance of education regarding the usage of the device. Of the 50 family physicians, only three stated that they did not know the devices. However, in the evaluation of the usage with demonstration devices, the rates of correct usage were quite low. In the study by Ünlü et al. (17) , in which the knowledge of health workers on the usage of inhaler device was evaluated, they found the rates of correct usage as 76.8% for MDI, 50.8% for turbuhaler, and 44.5% for discus. The mean skill rate was 6.94 for MDI, 4.86 for turbuhaler, and 4.15 for discus. In our study, skill rates for MDI, discus, and turbuhaler were a little higher than those in this study. The device that was similarly applied in a more accurate manner was MDI. Plaza et al. (18) reported in their study that the knowledge of physicians on inhaler devices was insufficient and new educational programs were needed, particularly the practicing physicians should be targeted in education. In INTEDA-1, which is the most recent study that has been conducted on physicians and inhaler usage in our country, the views of a total of 684 physicians on inhaler usage were evaluated through the questionnaire technique. Most of the physicians participating in this study were specialists and residents working in the departments of chest diseases (37.5%) and pediatrics (38.1%), respectively. The rate of physicians working as family physicians and practicing physicians was 13.3%. Only 18.5% of the participants specified that they had enough knowledge on inhaler usage. Of the physicians, 70% provided education on inhaler usage themselves while prescribing the drug for the first time, and most of them provided education to the patient verbally. A total of 98% of physicians participating in the study mentioned that an extensive education on inhaler usage was needed for physicians and other health staff (19) .
It is clear that the education should not be limited to only one session, and all health workers should be involved in regular educational programs. In our study, it was observed that physicians receiving education and physicians explaining the device to the patient were correlated. Most of our physicians stated that they were highly pleased with the visit; thus, they had an opportunity for reviewing the steps in the usage of the inhaler devices in which they were not efficient. Our study demonstrated that the education provided on the usage of inhaler devices created more awareness among health staff.
CONCLUSION
Primary care physicians have important responsibilities for the prevention of the incorrect usage of inhaler devices by patients. Our study revealed that family physicians had shortcomings regarding the usage of inhaler devices, and it was thought that in-service training regarding inhaler devices would lead to a significant increase in the awareness of this issue.
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